Key facts
- This page summarizes Joseph K. Belanoff's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jun 2026, 16:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Gift
Gift
Gift
Sale
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
Footnote F2
Transfer of shares without consideration to the Joseph K. Belanoff 2026 Grantor Retained Annuity Trust.
Footnote F3
Shares are held by Joseph K. Belanoff 2026 Grantor Retained Annuity Trust, of which the Reporting Person is the trustee.
Footnote F4
Transfer of shares without consideration to the Katherine A. Blenko 2026 Grantor Retained Annuity Trust.
Footnote F5
Shares are held by Katherine A. Blenko 2026 Grantor Retained Annuity Trust, of which the spouse of the Reporting Person is the trustee.
Footnote F6
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction.
SEC remarks
The power of attorney under which this form was signed is on file with the Commission.